• Ancillary Program

     
     
     
    Type Size
     

    Friday, October 12

    Nutrition Working Group
    7:15 pm – 9:30 pm
    Registration Fee: $25

    Supported by an educational grant from Dairy Research Institute

    Role of Diet and Endocrine Factors Regulating Bone Due to Weight Change
    An overview of weight loss and bone by Sue Shapses will be followed by presentations on: 1) diet and exercise interventions and bone during weight loss, by Stuart Phillips; 2) the role of leptin and PTH in regulating bone during weight change, by Irszula Iwaniec; 3) anorexia nervosa, by Michelle Warren; and 4) bone loss in adolescents after bariatric surgery, by Heidi Kalkwarf. A plated dinner will precede the program.

    For further information, please contact:
    Connie M. Weaver, Ph.D.
    Purdue University, Nutrition Science
    Tel: +1 (765) 494-8237
    Email: weavercm@purdue.edu


    Muscle and Bone Working Group

    7:30 pm – 9:30 pm
    Eighth Annual Meeting
    Registration Fee: $30

    Muscle-Bone Relationships in the Young and Old
    The largest forces on skeletons come from muscle contractions. This suggests that changes in muscle strength should cause changes in bone strength. This idea has been tested and observed in several studies of growing children, immobilized individuals and in the elderly. There will be four 20-minute expert talks about specific aspects of the muscle-bone interaction in these varied populations. A box dinner will precede the program.

    For further information, please contact:
    Christopher L. Gordon, Ph.D.
    McMaster University, Department of Radiology
    Tel: +1 (905) 628-5677
    Email: chrisgordon@sympatico.ca


    Working Group on Skeletal Aging
    7:30 pm – 9:30 pm
    Registration Fee: $40

    Aging and Skeletal Regulation of Metabolism
    The program will consist of four talks and panel discussions on metabolism and the aging skeleton. Topics will include metabolic factors that influence skeletal aging (Jane Cauley,University of Pittsburgh), the skeleton as an endocrine organ regulating glucose metabolism (Stavroula Kousteni, Columbia University), the effects of caloric restriction on the skeleton (Lyndon Joseph, NIH/NIA) and bone-fat

    reciprocity with skeletal aging (Robert Pignolo, University of Pennsylvania). A panel discussion and audience participation will be moderated by one of the working group organizers. A dinner will precede the program.

    For further information, please contact:
    Robert J. Pignolo, M.D., Ph.D.
    University of Pennsylvania
    Tel: +1 (215) 573-1514 or +1 (215) 898-8653
    Email: pignolo@mail.med.upenn.edu


    Adult Bone and Mineral Working Group
    7:30 pm – 10:00 pm
    Registration Fee: $40

    Supported by an educational donation from Amgen and Alexion

    The program will open with a brief historical vignette followed by 10–15 clinical abstract presentations. There will be a brief question and-answer session following the abstract presentations. The session will conclude with the Presentation of the Boy Frame Award for Clinical Excellence in the Field of Bone and

    Mineral Research, which is awarded to the senior author of a presented abstract based on overall merit as judged by the Adult Bone and Mineral Working Group Chair and Co-Chairs prior to the meeting.

    For further information, please contact:
    Fergus E. McKiernan, M.D.
    Center for Bone Diseases, Marshfield Clinic
    Tel: +1 (715) 389-7730
    Email: mckiernan.fergus@marshfieldclinic.org


    The CKD-MBD Working Group
    7:30 pm – 10:00 pm
    Registration Fee: $20

    Updates on Pi, FGF23, and VDRA in the CKD-MBD
    The program will consist of three talks followed by selected abstract presentations which will be chosen from the ASBMR poster program. Topics will include Status of Pi as a CV risk factor (Sharon Moe, Indiana University), Status of FGF23 – uremic toxin or risk factor (Myles Wolf, Massachusetts General Hospital), and Prospective analysis of VDRA therapy on CV risk – The Primo Study (Ravi Thadhani, Massachusetts General Hospital Harvard University). A plated dinner will precede the program.

    For further information, please contact:
    Keith A. Hruska, M.D.
    Washington University in St. Louis School of Medicine
    Tel: +1 (314) 286-2772
    Email: hruska_k@kids.wustl.edu

    and

    Sharon Martin Moe, M.D.
    Indiana University
    Tel: +1 (317) 278-2868
    Email: smoe@iupui.edu

    Sunday, October 14


    Pediatric Bone and Mineral Working Group

    7:15 pm – 9:30 pm
    Registration Fee: $35

    Bone and Mineral Issues in Pediatric Patients with Chronic Kidney Disease
    The working group will begin with Opening Remarks from the Session Chair, Dr. Erik Imel, Indiana University. The program will consist of five talks, covering the following topics: 2012-The Year in Pediatric Bone Disease; Pediatric Chronic Kidney Disease-Mineral Bone Disorders: Importance of Phosphotropic Hormones; Pediatric Chronic Kidney Disease-Mineral Bone Disorders: Effects on Skeletal Structure and Microarchitecture; Treatment of Bone Disease in Pediatric Patients with CKD; and Bone Disease in the Pediatric Kidney Transplant Recipient. A plated dinner will precede the program.

    For further information please contact:
    Erik A. Imel, M.D.
    Indiana University School of Medicine
    Email: eimel@iupui.edu



    Bone Strength Working Group
    7:15 pm – 9:45 pm
    Registration Fee: $25

    Sponsored by the Canadian Bone StrengthWorking Group
    Supported by unrestricted educational grants from Amgen Canada Inc. and Lilly Canada Inc.

    This program will be co-chaired by Robert Josse, M.D., University of Toronto, and Jacques Brown,M.D., Laval University. The program will begin with a welcome and introduction from Angela Cheung, M.D., Ph.D., University of Toronto, followed by presentations of top abstracts that the working group will select from the ASBMR Poster Program. The abstract presentations will be followed by a Keynote Debate entitled “Longterm Antiresorptive Therapy is Harmful to BoneStrength.” Dr. Cyrus Cooper will be debating “For” the argument and Dr. Michael McClung will be debating “Against.” After the debate there will be time set aside for questions and discussion/final vote. The working group will end with concluding remarks from Dr. Richard Kremer, M.D., Ph.D., McGill University. A plated dinner will precede the program.

    For further information, please contact:
    Richard Kremer, M.D., Ph.D.
    McGill University Health Center
    Tel: +1 (514) 843-1632
    Email: richard.kremer@mcgill.ca

    or

    Angela Cheung, M.D., Ph.D.
    University of Toronto
    Tel: +1 (416) 340-4301
    Email: angela.cheung@uhn.on.ca



    Rheumatic Diseases and Bone Working Group
    7:30 pm – 9:30 pm
    Registration fee: $50

    The Bone Component of Osteoimmunology
    The invited speakers and topics include: Thomas Einhorn on Inflammation and Bone: Lessons from Fracture Healing; Ellen Gravellese on Rheumatoid Arthritis: What Happens in Bone Marrow?; and Piet Geusens on Ankylosing Spondylitis: Effects of Biological on Osteitis and Syndesmophytes. A light dinner will be served.

    For further information please contact:
    Piet Geusens, M.D., Ph.D.
    University Hasselt
    Email: piet.geusens@scarlet.be


    Bone Turnover Markers Working Group
    7:30 pm – 9:30 pm
    Registration Fee: $30

    Bone Markers and their Role in Diabetes
    The meeting will cover bone markers and the potential interaction between bone turnover and disturbances in glucose homeostasis. In this respect, osteocalcin has earned most interest over the past years. In addition, vitamin D appears to play an important role as a player with effects on tissues beyond bone and hence linking bone to adipose tissue but also on through immune function. Questions to be addressed include: Can bone markers predict increased risk of bone loss in association with diabetes? Can bone markers be used to monitor treatment efficacy or identify risk of side-effects with anti-diabetic drugs? What information can be gained by combining established bone markers with novel metabolic markers: sclerostin, adiponectin, Fetuin-A, advanced glycation end products (AGEs)/pentosidine, in diabetes-associated bone alterations?

    For further information, please contact:
    Kristina Akesson, M.D., Ph.D.
    Lund University, Skåne University Hospital
    Tel:+ 46 40 33 2370
    Email: kristina.akesson@med.lu.se



    Rare Bone Disease Working Group
    7:30 pm – 9:30 pm
    Registration Fee: $25

    Rare Bone Disease Research – Present and Future
    This working group will be led by Dr. Jay Shapiro, Director of the Osteogenesis Imperfecta Clinic at Kennedy Krieger Institute and Professor, Department of Physical Medicine and Rehabilitation, at Johns Hopkins University. Experts from the rare bone disease community, including but not limited to osteogenesis imperfecta, fibrous dysplasia, melorheostosis, multiple hereditary exostoses, XLH,

    hypophosphatasia, fibrodysplasia ossificans progressiva and Gorham’s Disease, will present information on current research being conducted and the opportunities for scientists to engage in new research in any one of these disease areas. Experts will discuss ways rare bone research in one area could benefit and/or accelerate the research in another area. There will be ample time for questions and discussion.

    A light dinner will be served.

    For further information please contact:
    Tracy Hart
    Rare Bone Disease Patient Network
    Email: thart@oif.org


    Working Group on Musculoskeletal Rehabilitation in Patients with Osteoporosis
    7:30 pm – 9:30 pm
    14th Annual Meeting
    Registration Fee: $25

    Non-pharmacologic Management of Osteoporosis
    The program will be selected by Core Members of our Working Group from submitted abstracts to the ASBMR official program using the following key words: Exercise (Bone, Joint, Muscle), Nutrition,  Orthopaedics (Mechanical Loading), Treatments (Non-pharmacological treatment) and Hip Fracture Rehabilitation. In addition, special lectures highlighting new developments in our field will be given. These lectures will be invited by the scientific committee of our group (“Core Members”).

    For further information, please contact:
    Mehrsheed Sinaki, M.D.
    Mayo Clinic and Mayo Clinic College of Medicine
    Tel: +1 (507) 284-2608
    Email: sinaki.mehrsheed@mayo.edu

    and

    Michael Pfeifer, M.D.
    Institute of Clinical Osteology Gustav Pommer and Medwiss Bad Pyrmont
    Telephone: +49-5281-151414
    Email: mdrpfeifer@aol.com



    The International Chinese Hard Tissue Society (ICHTS) Webster S.S. Jee Musculoskeletal Summit Workshop
    Thursday, October 11, 2012

    The ICHTS Webster S.S. Jee Musculoskeletal Summit Workshop aims to provide high-level research exchanges among senior ICHTS investigators, help career and research advances of young investigators and fundraise for the Webster S.S. Jee Endowment for supporting future young ICHTS members. This is a unique Summit Workshop that allows senior ICHTS members to have in-depth exchanges in science and discoveries in musculoskeletal research and provides an excellent forum for young ICHTS investigators to participate and interact with senior ICHTS members. To register for this  workshop and for more meeting details, visit www.ichts.org

    The International Society for Clinical Densitometry (ISCD)

    Please note that the International Society for Clinical Densitometry (ISCD) courses are not part of the ASBMR Official Scientific Program and have been organized by ISCD. The ISCD sessions are held in conjunction with the ASBMR Annual Meeting and require a separate registration and fee. To register for this course, or for additional information regarding The International Society for Clinical Densitometry, visit www.iscd.org or call +1 (860) 259-1000.

    The core elements of the ISCD Bone Densitometry Course provide a set of standard practices and information to raise the level of awareness and education in bone densitometry. The course emphasizes central DXA testing. In addition, a solid foundation in other forms of bone mass measurement, including peripheral DXA and QCT is provided.

    The ISCD Bone Densitometry Course will take place on Wednesday and Thursday, October 10-11

    Clinician Track (open to M.D.s, Ph.D.s, D.O.s, Nurse Practitioners and Physician Assistants) is most appropriate for those involved in the interpretation of DXA scans.

    Technologist Track (open to Technologists and Allied Health Professionals) is most appropriate for those involved in the performance of the bone densitometry examination. Technologists may attend the Clinician Course if gaining information about interpreting DXA scans would assist them with their job responsibilities. However, it is recommended that the Technologist Course be taken first.

    Accreditation Statement The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians.